Vancouver, B.C., June 17, 2021 – Further to its press release date May 17, 2021, Awakn Life Sciences Corp. (formerly 1169082 B.C. Ltd.) (the “Company”) is pleased to announce that it has completed its reverse takeover transaction (the “Transaction”) of Awakn Life Sciences Inc. (“Awakn”), and that the net proceeds from its previously announced brokered private placement of 3,320…


Previous articleMYND Life Sciences Announces LOI with Eyam Vaccines and Immunotherapeutics
Next articleDiamond Therapeutics contracts BioPharma Services for Phase 1 clinical trial